Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.